About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

NCT00961909·6 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hoffmann-La Roche

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

adult patients, 18-65 years of age
females who are either surgically sterile or post-menopausal
type 2 diabetes treated with a stable dose of metformin
BMI between 25-39kg/m2
HbA1c between 7 and 10%
fasting plasma glucose between 7 and 13.3mmol/L

You may not be if

history of clinically significant cardiovascular disease
history of clinically significant hepatic or renal disease or impairment
recent therapy with insulin, thiazolidinedione, glucagon-like peptide-1 analogues, amylin analogues and/or DPP-IV inhibitors

The record

StatusCompleted

PhasePhase 1

Taking part122

StartedJun 2009

UpdatedNov 2, 2016

Conditions

Diabetes Mellitus Type 2

Where6

Anaheim, California, United States
Chula Vista, California, United States
Fort Myers, Florida, United States